JMJD3/HDAC-IN-1 is used to inhibit cancer cell colony formation, migration, and invasion; induce apoptosis through cleavage of caspase-7 and PARP; and promote hypermethylation of histone H3K27 and hyperacetylation of H3K9 by dual inhibition of JMJD3 and HDAC1.